Ischemia-reperfusion injury of liver and therapeutic intervention

Hepatology Research

Volumn 16, Issue 3, 2000, Pages 233-253

  Marubayashi, Seiji ^a   Asahara, Toshimasa ^a   Dohi, Kiyohiko ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Free radical; Ischemia reperfusion injury; Kupffer cells; Neutrophil; Nuclear factor kB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; GRAFT REJECTION; KUPFFER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFERENCE VALUE; REPERFUSION; SIGNAL TRANSDUCTION;

EID: 0034141572     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00055-8     Document Type: Article

References (165)

1. Seaberg E.C., Belle S.H., Beringer Kc., Schivins J.L., Detre K.M. Long-term patient and retransplantation-free survival by selected recipient and donor characteristics: an update from the Pitt-UNOS liver transplant registry. Cecka J.M., Terasaki P.I. Clinical Transplants. 1997;15-28.
2. Starzl T.E., Demetris A.J., van Thiel D. Liver transplantation. New Engl. J. Med. 321:1989;1014-1022.
3. Otte J.B. Recent development in liver transplant. J. Hepatol. 12:1991;386-393.
4. Todo S., Nevy J., Yanaga K., Podesta L., Gordon R.D., Starzl T.E. Extended preservation of human liver grafts with UW solution. J. Am. Med. Assoc. 26:1989;711-714.
5. Furukawa H., Todo S., Imventarza O. et al. Effect of cold ischemia time the early outcome of human hepatic allografts preserved with UW solution. Transplantation. 51:1991;1000-1004.
6. Howard Tk., Gordon B., Klintmalm G. et al. The influence of preservation injury on rejection in the hepatic transplant recipients. Transplantation. 49:1990;103-107.
7. Clavien P.A., Harvey P.R.C., Slasbery S.M. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 53:1992;957-978.
8. Marubayashi S., Takenaka M., Dohi K., Ezaki H., Kawasaki T. Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation. 30:1980;294-296.
9. Marubayashi S., Dohi K., Ezaki H., Hayashi K., Kawasaki T. Preservation of ischemic rat liver mitochondrial functions and liver viability with CoQ10. Surgery. 91:1982;631-637.
10. Marubayashi S., Dohi K., Yamada K., Kawasaki T. Changes in the levels of endogenous coenzymeQ homologs, α-Tocopherol, and glutathione in rat liver after hepatic ischemia and reperfusion and the effect of pretreatment with coenzyme Q10. Biochem. Biophys. Acta. 797:1984;1-9.
11. Marubayashi S., Dohi K., Kawasaki T. Role of free radicals in ischemic rat liver cell injury. Prevention of damage by α-tocopherol administration. Surgery. 99:1986;184-191.
12. Kawasaki T., Marubayashi S. Liver in shock. Barett J.M., Nyhus L.M. Treatment of Shock. 2nd ed. 1986;151-162 Lea and Febiger, Philadelphia, PA.
13. Marubayashi S., Dohi K., Sugino K., Kawasaki T. The protective effect of administered α-tocopherol against hepatic damage caused by ischemia reperfusion or endotoxemia. Ann. N.Y. Acad. Sci. 570:1989;208-218.
14. Marubayashi S., Dohi K., Yamada K., Kawasaki T. Role of conversion of xanthine dehydrogenase to oxidase in ischemic rat liver cell injury. Surgery. 110:1991;537-543.
15. Marubayashi S., Dohi K. Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications. Surg. Today. 26:1996;573-580.
16. Takenaka M., Tatsukawa Y., Dohi K., Ezaki H., Matsukawa K., Kawasaki T. Protective effect of α-tocopherol and coenzyme Q10 on warm ischemic damage of the rat kidney. Transplantation. 32:1982;137-141.
17. Yamamoto M., Shima T., Uozumi T., Sogabe T., Yamada K., Kawasaki T. A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of α-tocopherol administration. Stroke. 14:1983;977-982.
18. Sugino K., Dohi K., Yamada K., Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery. 101:1987;746-752.
19. Sugino K., Dohi K., Yamada K., Kawasaki T. Changes in the level of endogenous antioxidants in the liver of mice with experimental endotoxemia and protective effect of antioxidants. Surgery. 105:1989;200-206.
20. Sumimoto K., Inagaki K., Kawasaki T., Dohi K. Ischemic damage prevention by coenzyme Q10 treatment of the donor before orthotopic liver transplantation: Biochemical and histologic findings. Surgery. 102:1987;821-828.
21. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1:1987;358-364.
22. Dohi K., Asahara T., Fukuda Y., Marubayashi S., Yahata H., Hong H. Successful treatment by simultaneous hepatic venoplasty and cavoplasty for Budd-Chiari syndrome with obstruction of retrohepatic vena cava. Surgery. 113:1993;574-579.
23. Breizi K.I., Dawkes R., Dodd Nj., Plevris J.N., Hyes P.C. Graft dysfunction following liver transplantation: role of free radicals. J. Hepatol. 26:1997;69-74.
24. Rao P.N., Walsh T.R., Makowka L. et al. Inhibition of free radical generation and improved survival by protection of the hepatic microvascular endothelium by targeted erythrocytes in orthotopic liver transplantation. Transplantation. 49:1990;1055-1059.
25. Toledo-Pereyra L.H., Simmons R.L., Najarian J.S. Protection of the ischemic liver by donor pretreatment before transplantation. Am. J. Surg. 129:1975;513-517.
26. Vreugdenhil R.K., Rankin M.A., Southard J.H. Cold storage sensitizes hepatocytes to oxidative stress injury. Transplant Int. 10:1997;379-385.
27. Cerwenka H., Bacher H., Werkgartner G. et al. Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepatogastroenterology. 45:1998;777-782.
28. Demir S., Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin. Chim. Acta. 275:1998;127-135.
29. Nakano H., Boudjema K., Jaeck D. et al. Amerioration of hepatocellular integrity and inhibition of sinusoidal oxidative stress by N-acetylcysteine pretreatment in cold ischemia-reperfusion injury of rat liver. Eur. Surg. Res. 28:1996;244-255.
30. 3-levels. J. Surg. Res. 66:1996;131-137.
31. Todo S., Hamada N., Zhu Y. et al. Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation. 61:1996;189-194.
32. Liu P., McGuire G.M., Fisher M.A., Farhood A., Smith C.W., Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock. 3:1995;56-62.
33. Wu T.W., Hashimoto N., Au J.X., Wu J., Mickle D.A., Carey D. Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology. 13:1991;575-580.
34. Wu T.W., Fung K.P., Zeng L.H., Wu J., Nakamura H. Propyl gallate as a hepatoprotector in vitro and in vivo. Biochem. Pharmacol. 48:1994;419-422.
35. Wu T.W., Zeng L.H., Wu J., Fung K.P. Morin hydrate is a plant-derived and antioxidant-based hepatoprotector. Life. Sci. 53:1993;PL213-218.
36. Minor T., Chung C.W., Yamamoto Y., Obara M., Saad S., Isselhard W. Evaluation of antioxidant treatment with superoxide dismutase in rat liver transplantation after warm ischemia. Eur. Surg. Res. 24:1992;333-338.
37. Salaris S.C., Babbs C.F., Voorhees W.D. Methylene blue as an inhibitor of superoxide generation. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem. Pharmacol. 42:1991;499-506.
38. Myagkaya G., van Veen H., James J. Ultrastructural changes in rat liver sinusoids during prolonged normothermic and hypothermic ischemia in vitro. Virchows Arch. B47:1984;361-373.
39. Hollway C.M., Harvey P.R., Mullen J.B., Strasberg S.M. Evidence that cold preservation-induced microcirculatory injury in liver allografts is not mediated by oxygen-free radicals or cell swelling in the rat. Transplantation. 48:1989;179-188.
40. Koizumi M., Ohkohochi N., Katoh H. et al. Preservation and reflow damage in liver transplantation in the pig. Transplant Proc. 21:1989;1323-1326.
41. McKeown C.M.B., Edwards V., Philips M.J., Harvey P.R.C., Petrumka C.N., Strasberg S.M. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation. 46:1988;178-182.
42. Caldwell-Kenkel J.C., Currin R.T., Tanaka Y., Thurman R.G., Lemasters J.J. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology. 10:1989;292-299.
43. Lindell S.L., Southard J.H., Vreugdenhil P., Belzer F.O. Kupffer cells depress hepatocyte protein synthesis on cold storage of the rat liver. Transplantation. 58:1994;869-874.
44. Marzi I., Zhong Z., Lemasters J.J., Thurman R.G. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation. The importance of nonparenchymal cells. Transplantation. 48:1989;463-468.
45. Gerlach J.C., Hentschl F., Spatkowski G., Zeilinger K., Smith M.D., Neuhaus P. Cell detachment during sinusoidal reperfusion after liver preservation: an in vitro model. Transplantation. 64:1997;907-912.
46. Mochida S., Arai M., Ohno A. et al. Oxidative stress in hepatocytes and stimulatory state of Kupffer cells after reperfusion differ between warm and cold ischemia in rats. Liver. 14:1994;234-240.
47. Sumimoto R., Kamada N., Jamieson N.V., Fukuda Y., Dohi K. A comparison of a new solution combining histidine and lactobionate with UW solution and Euro Collins for rat liver preservation. Transplantation. 51:1991;589-593.
48. Sumimoto R., Lindell S.L., Southard J.H., Belzer F.O. A comparison of histidine-lactobionate and UW solution in 48-hour liver preservation. Transplantation. 51:1992;589-593.
49. Okuda M., Ikai I., Chance B., Kumar C. Oxygen radical production during ischemia-reperfusion in the isolated perfused rat liver as monitored by luminol enhanced chemiluminescence. Biochem. Biophys. Res. Commun. 174:1991;217-221.
50. Brass C.A., Nunes F., Nagpal R. Increased oxyradical production during reoxygenation of perfused rat liver. Transplantation. 58:1994;1329-1335.
51. Connor H., Gao W., Nukina S., Lemasters J.J., Mason R.P., Thurman R.G. Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the ratan electron paramagnetic resonance spin trapping study. Transplantation. 58:1994;1329-1335.
52. Togashi H., Shinzawa H., Yong H. et al. Ascorbic acid radical, superoxide, and hydroxyl radical are detected in reperfusion injury of rat liver using electron spin resonance spectroscopy. Arch. Biochem. Biophys. 308:1994;1-7.
53. Granger D.N., Rutili G., McCord J.M. Role of superoxide radicals in intestinal ischemia. Gastroenterology. 81:1981;22-29.
54. DcGroot H., Littauer A. Reoxygenation injury in isolated hepatocytes: cell death proceeded conversion of xanthine dehydrogenase to xanthine oxidase. Biochem. Biophys. Res. Commun. 155:1988;278-282.
55. Metzger J., Dore S.P., Lauterburg B.H. Oxidant stress during reperfusion of ischemic liver: no evidence for a role of xanthine oxidase. Hepatology. 8:1988;580-584.
56. Yokoyama Y., Beckman J.S., Beckman T.K. et al. Circulating xanthine oxidase: potential mediator of ischemic injury. Am. J. Physiol. 258:1990;G564-570.
57. Toledo-Pereyra L.H., Simmons R.L., Najarian J.S. Effect of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes. Ann. Surg. 180:1974;780-782.
58. Das D.K., Engelman R.M., Clement R., Otani H., Prasad M.R., Rao P.S. Role of oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem. Biophys. Res. Commun. 148:1987;314-319.
59. Moorhouse P.C., Grootveld M., Halliwell B., Quinlan J.G., Gutteridge J.M.C. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett. 213:1987;23-28.
60. Peterson D.A., Kelly B., Gerrard J.M. Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury? Biochem. Biophys. Res. Commun. 137:1986;76-79.
61. Karwinski W., Soreide O. Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury. Liver. 17:1997;139-143.
62. Nordstrom G., Seeman T., Hasselgren P.O. Beneficial effect of allopurinol in liver ischemia. Surgery. 97:1985;679-684.
63. Wardle E.N. Kupffer cells and their function. Liver. 7:1987;63-75.
64. Lemasters J.J., Thurman R.G. Reperfusion injury after preservation for transplantation. Ann. Rev. Pharmacol. Toxicol. 37:1997;328-338.
65. Shibuya H., Ohkouchi N., Tsukamoto S., Satomi S. Tumor necrosis factor-α induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfusion rat liver. Hepatology. 26:1997;113-120.
66. Carrick J.B., Martins O., Snider C.C. et al. The effect of LPS on cytokine synthesis and lung neutrophil influx after hepatic ischemia/reperfusion injury in the rat. J. Surg. Res. 68:1997;16-23.
67. Lindert K.A., Caldwell-Kenkel J.C., Nukina S., Lemasters J.J., Thurmaan R.G. Activation of Kupffer cells on reperfusion following hypoxia: partial phagocytosis in a low-flow, relow model. Am. J. Physiol. 262:1992;345-350.
68. Arii S., Monden K., Adachi Y. et al. Pathogenic role of Kupffer cell activation in the reperfusion injury of cold-preserved liver. Transplantation. 58:1994;1072-1077.
69. Caldwell-Kenkel J.C., Currin R.T., Tanaka T., Thurman R.G., Lemasters J.J. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology. 13:1991;83-95.
70. Deaciuc I.V., Bagby G.J., Niesman M.R., Skrepnik N., Spitzer J.J. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intracellular communication in the liver. Hepatology. 19:1994;464-470.
71. Marzi I., Cowper K., Takei Y., Lindert K., Lemasters J.J., Thurman R.G. Methylpalmitate prevents Kupffer cell activation and improves survival after orthotopic liver transplantation in the rat. Transplant Int. 4:1991;215-220.
72. Li X.K., Matin A.F.M., Suzuki H., Uno T., Yamaguchi T., Harada Y. Effect of protease inhibitor on ischemia-reperfusion injury of the rat liver. Transplantation. 56:1993;1331-1336.
73. Takei Y., Marzi I., Kauffman F.C., Currin R.T., Lemasters J.J., Thurman R.G. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker nisoldipine. Transplantation. 50:1990;14-20.
74. Ohdan H., Fukuda Y., Urushihara T. et al. Synergistic effects of nafamostat mesilate rinse and Kupffer cell blockade for rat liver transplantation. Transplant Int. 9(Suppl. 1):1996;S447-451.
75. Fukuma K., Marubayashi S., Okada K., Yamada K., Kimura A., Dohi K. Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery. 125:1999;421-430.
76. Okada K., Marubayashi S., Fukuma K. et al. Effect of lazaroid on TNF-α release and NF-kB activation of Kupffer cell in endotoxin-induced liver cell injury. Shock. 3:1998;33. abstract.
77. Goto M., Takei Y., Kawano S. et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology. 16:1992;487-493.
78. Okuaki Y., Miyazaki H., Zeniya M. et al. Splenectomy-reduced hepatic injury induced by ischemia-reperfusion in the rat. Liver. 16:1996;188-194.
79. Sankary H.N., Foster P., Brown E., Williams J. Do splanchnic viscera contribute to liver preservation reperfusion injury? Transplantation. 61:1996;1142-1147.
80. +T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J. Clin. Invest. 100:1997;279-289.
81. Reinders M.E., Wagensveld B.A., van Gulik T.M. et al. No attenuation of ischemic and reperfusion injury in Kupffer cell-depleted, cold-preserved rat livers. Transplantation. 63:1997;449-454.
82. Imamura H., Sutto F., Braut A., Huet P.M. Role of Kupffer cells in cold ischemia/reperfusion injury of rat liver. Gastroenterology. 109:1995;189-197.
83. Jaeschke H., Farhood A., Smith C.W. Neutrophils contribute to ischemic/reperfusion injury in rat liver in vivo. FASEB J. 4:1990;3355-3359.
84. Kuroda T., Shiohara E. Leukocyte and platelet depletion protects the liver from damage induced by cholestasis and ischemia-reperfusion in the dog. Scand. J. Gastroenterol. 31:1996;182-190.
85. Jaeschke H., Farhood A., Bautista A.P., Spolarics Z., Spitzer J.J. Complement activates Kupper cells and neutrophils during reperfusion after hepatic ischemia. Am. J. Physiol. 264:1993;G801-809.
86. Jaeschke H., Smith C.W. Mechanism of neutrophil-induced parenchymal cell injury. J. Leukoc. Biol. 61:1997;647-653.
87. Jaeschke H. Mechanism of reperfusion injury after warm ischemia of the liver. J. Hepatobiliary Pancreat. Surg. 5:1998;402-408.
88. Marubayashi S., Oshiro Y., Maeda T. et al. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery. 122:1997;45-52.
89. Oshiro Y., Marubsyashi S., Maeda T. et al. Contribution of neutrophils to and effect of monoclonal antibodies of adhesion molecules on ischemia and reperfusion injury in rat liver. Transplant Proc. 27:1995;743-744.
90. Maeda T., Marubasayashi S., Oshiro Y., Sugino K., Dohi K. Effects of antileukocyte adhesion molecule antibodies, nitric oxide synthase inhibitor, and methyl-prednisolone on endotoxin-shock in mice. Surg. Today. 27:1997;22-29.
91. Takei Y., Marzi I., Gao W., Gores G.J., Lemasters J.J., Thurman R.G. Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat. Transplantation. 51:1991;959-965.
92. Bautista A.P., Spitzer J.J. Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Rad. Res. Commun. 17:1992;195-209.
93. Serizawa A., Nakamura S., Suzuki S., Baba S., Nakano M. Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology. 23:1996;1656-1663.
94. Maher J.J., Scott M.K., Saito L.M., Burton M.C. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a netrophil hepatitis. Hepatology. 25:1997;624-630.
95. Zhang P., Xie M., Zagorski J., Spitzer J.A. Attenuation of hepatic neutrophil sequestration by anti-CINC antibody in endotoxin rats. Shock. 4:1995;262-268.
96. Simonet W.S., Hughes T.M., Nguyen H.Q., Trebasky L.D., Danilenko D.M., Medlock E.S. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94:1994;1310-1319.
97. Yamaguchi Y., Akizuki E., Ichiguchi O. et al. Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischemia-reperfusion in rat liver. Gastroenterology. 112:1997;551-560.
98. Hisama N., Yamaguchi Y., Ishiko T. et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology. 24:1996;1193-1198.
99. Colletti L.M., Kunkel S.L., Green M., Burdick M.D., Strieter R.M. Hepatic inflammation following 70% hepatectomy may be related to upregulation of epithelial neutrophil activating protein-78. Shock. 6:1996;397-402.
100. Colletti L.M., Kunkel S.L., Walz A. et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 23:1996;506-514.
101. 2 integrins and intercellular adhesion molecule-1. Shock. 6:1996;345-350.
102. Andrian U.H.V., Chambers J.D., McEvoy L.M., Bargatze R.F. Two step model of leukocyte-endothelial cell interaction: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc. Natl. Acad. Sci. 88:1991;7538-7542.
103. Weyrich A.S., Xin-Liang M.A., Lefer D.J. et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
104. Lefer A.M., Xin-Liang M.A. Adherence to cat ischemia-reperfused mevascular endothelium under flow: role of P-selectin. J. Appl. Physiol. 76:1994;33-38.
105. Sanders W.E., Wilson R.W., Ballantyne C.M., Beaudet A.L. Molecular cloning and analysis of in vivo expression of murine P-selectin. Blood. 80:1992;795-800.
106. Garcia-Criado F.J., Toredo-Pereyra L.H., Lopez-Neblina F., Phillips M.L., Paez-Rollys A., Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J. Am. Coll. Surg. 181:1995;327-334.
107. Kurose I., Anderson D.C., Miyasaka M. et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Cir. Res. 74:1994;336-343.
108. Okada Y., Copeland B.R., Mori E. et al. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 25:1994;202-211.
109. Albelda S.M., Buck C.A. Integrins and other adhesion molecules. FASEB J. 4:1990;2868-2880.
110. Granger D.N., Benoit J.N., Saluki M., Gresham M.B. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol. 257:1989;G683-688.
111. Suzuki M., Inauen W., Kvietys P.R. et al. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am. J. Physiol. 257:1989;H1740-1745.
112. Vedder N.B., Winn R.K., Rice C.L., Chi E.Y., Afrors K.E., Hadrian J.M. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein CD18 reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J. Clin. Invest. 31:1988;939-944.
113. Anderson D.C., Springer T.A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and pl50,95 glycoproteins. Annu. Rev. Med. 38:1987;175-194.
114. Smith C.W., Marlin S.D., Rothlein R., Timon C., Anderson C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83:1989;2008-2017.
115. Jaeschke H., Farhood A., Bautista A.P., Spolarics Z., Spitzer J.J., Smith C.W. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology. 17:1993;915-923.
116. Jaeschke H., Farhood A., Smith C.W. Neutrophil-liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 261:1991;G1051-1056.
117. Simposon P.J., Todd R.F., Mickelson J.K. et al. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation. 81:1990;226-237.
118. Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 166:1987;1685-1701.
119. Horie Y., Wolf R., Miyasaka M., Anderson D.C., Granger D.N. Leukocyte adhesion and hepatic microvascular reponses to intestinal ischemia/reperfusion in rats. Gastroenterology. 111:1996;666-673.
120. Horie Y., Wolf R., Anderson D.C., Granger D.N. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J. Clin. Invest. 99:1997;781-788.
121. Shi J., Fujieda H., Kokubo Y., Wake K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology. 24:1996;1256-1263.
122. McCuskey R.S., Urbaschek R., Urbaschek B. The microcirculation during endotoxemia. Cardiovasc. Res. 32:1996;752-763.
123. Bauer M., Zhang J.X., Bauer I., Clemens M.G. Endothelin-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action. Am. J. Physiol. 267:1994;G143-149.
124. Nakamura S., Nishiyama R., Serizawa A. et al. Hepatic release of endothelin-1 after warm ischemia. Transplantation. 59:1995;679-684.
125. Goto M., Takei Y., Kawano S. et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology. 19:1994;675-681.
126. Okumura S., Takei Y., Kawano S. et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology. 19:1994;155-161.
127. Nishida J., McCuskey Rs., McDonnell D., Fox E.S. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am. J. Physiol. 267:1994;G1134-1141.
128. Suematsu M., Goda N., Sano T. et al. Carbon monoxide: An endogenous modulator of sinusoidal tone in the perfused rat liver. J. Clin. Invest. 96:1995;2431-2437.
129. Sano T., Shiomi M., Wakabayashshi Y. et al. Endogenous carbon monoxide suppression stimulates bile acid-dependent biliary transport in perfused rat liver. Am. J. Physiol. 272:1997;G1268-1275.
130. Worthen C.S., Schwab B., Elson E.L., Downey C.P. Mechanics of stimulated neutrophils: cell stiffening retention in capillaries. Science. 245:1989;183-186.
131. Entman M.I., Smith C.W. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc. Res. 28:1994;1301-1311.
132. Granger D.N., Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leukoc. Biol. 55:1994;662-675.
133. Essani N.A., Fisher M.A., Farhood A., Manning A.M., Smith C.W., Jaeschke H. Cytokine-induced hepatic intercellular adhesion molecules-1 (ICAM-1) mRNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology. 21:1995;1632-1639.
134. Essani N.A., Bajt M.L., Vonderfecht S.L., Farhood A., Jaeschke H. Transcriptional activation of vascular cell adhesion molecule-1 (VCAM-1) gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J. Immunol. 158:1997;5941-5948.
135. Suzuki S., Toledo-Pereyra L.H. Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transpl. Proc. 26:1994;325-327.
136. Toledo-Pereyra L.H., Suzuki S. Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury. Am. Coll. Surg. 179:1994;758-762.
137. Kelly K.J., Williams W.W. Jr, Colvin R.B., Bonventre J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proct. Natl. Acad. Sci. 91:1994;812-816.
138. Smith C.W. Transendothelial migration. Harlan J.M., Liu D.Y. Adhesion. Its Role in Inflammatory Disease. 1992;83-115 WH Freeman Co, New York.
139. Ma X., Lefer D.J., Lefer A.M., Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:1992;937-946.
140. Clark W.M., Madden K.P., Rothlein R., Zivin J.A. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75:1991;623-627.
141. Nakano H., Nagasaki H., Barama A. et al. The effect of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology. 26:1997;670-678.
142. Kurume M., Nakano H., Yamaguchi M. et al. A monoclonal antibody against ICAM-1 suppresses hepatic ischemia-reperfusion injury in rats. Eur. Surg. Res. 29:1997;93-100.
143. Nishimura Y., Takei Y., Kawano S. et al. The F (ab′)2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation. Transplantation. 61:1996;99-104.
144. Kiuchi T., Oldhafer K.J., Schlitt H.J. et al. Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study. Transplantation. 66:1998;737-747.
145. Strieter R.M., Lynch J.P. III, Basha M.A., Standiford T.J., Kasahara K., Kunkel S.L. Host responses in mediating sepsis and the adult respiratory distress syndrome. Semin. Respir. Infect. 5:1990;233-247.
146. Yoshimura T., Matsushima K., Oppenheim J.J., Leonard E.J. Neutrophil chemotactic factor produced by LPS-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1. J. Immunol. 139:1987;788-793.
147. Vollmar B., Richter S., Menger N.D. Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking. Liver. 17:1997;93-98.
148. Thornton A.J., Strierter R.M., Lindley I., Baggiolini M., Kunkel S.L. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J. Immunol. 144:1990;2609-2613.
149. Shiratori Y., Hikiba Y., Mawet E. et al. Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediators. Biochem. Biophys. Res. Commun. 203:1994;1398-1403.
150. Baeuerle P.A., Henkel T. Function and activation of Nf-kB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
151. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
152. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IKB by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
153. Stein B., Baldwin A.S. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and Nf-kB. Mol. Cell. Biol. 13:1993;7191-7198.
154. Shakhov An., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. kB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor gene in primary macrophages. J. Exp. Med. 171:1990;35-47.
155. Muraoka K., Shimizu K., Sun X. et al. Hypoxia, but not reoxygenation induces interleukin 6 gene expression through NF-kB activation. Transplantation. 63:1997;466-470.
156. Maniatis T. Catalysis by a multiprotein IkB kinase complex. Science. 278:1997;818-819.
157. Thanos D., Maniatis T. A lesson in family values. Cell. 80:1995;529-532.
158. Schreck R., Rieber P., Baeuerler P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
159. Schieven G.L., Kirihara J.M., Myers D.E., Ledbetter J.A., Uckun F.M. Reactive oxygen intermediates activate NF-kB in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p53lck and p59fyn tyrosine kinases in human lymphocytes. Blood. 82:1993;1212-1220.
160. Anderson M.T., Staaal F.J.T., Gitler C., Herzenberg L.A., Herzenber L.A. Separation of oxidant-initiated and redoxi-regulated steps in the NF-kB signal transduction pathway. Proc. Natl. Acad. Sci. 91:1994;11527-11531.
161. Essani N.A., Fisher M.A., Jaeschke H. Inhibition of NF-kB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene transcription and protection against endotoxin-induced liver injury. Shock. 7:1997;90-96.
162. Schmidt Kn., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kB. Chem. Biol. 2:1995;13-22.
163. Schibanuma M., Kuroki T., Nose K. Inhibition of N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF-kB by tumor necrosis factor in a mouse fibroblast cell line, Balb/3T3. FEBS Lett. 353:1994;62-66.
164. Kelly K.A., Hill M.R., Youkhana K., Wanker F., Gimble J.M. Dimethylsulfoxide modulates NF-kB and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect. Immun. 62:1994;3122-3128.
165. Manning A.M., Bell F.P., Rosenbloom C.L. et al. NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J. Inflamm. 45:1995;283-296.